Welcome to MyStelara (ustekinumab)
This website is intended for patients who live in the UK and have been prescribed Stelara® (ustekinumab) for Crohn's disease (CD) or ulcerative colitis (UC).
For information on Stelara® for plaque psoriasis (PsO) and psoriatic arthritis (PsA) indications, please consult the Patient Information Leaflet:
- If you are prescribed Stelara® as a 45mg pre-filled syringe, please consult the Patient Information Leaflet (PIL) for Great Britain or for Northern Ireland.
- If you are prescribed Stelara® as a 45mg pre-filled pen, please consult the Patient Information Leaflet (PIL) for Great Britain or for Northern Ireland.
- If you are prescribed Stelara® as a 90mg pre-filled syringe, please consult the Patient Information Leaflet (PIL) for Great Britain or for Northern Ireland.
- If you are prescribed Stelara® as a 90mg pre-filled pen, please consult the Patient Information Leaflet (PIL) for Great Britain or for Northern Ireland.
For members of the public, you can visit the Janssen UK website.
To enter the website, please confirm that you are a patient prescribed Stelara® for CD or UC by ticking the box below.
The information provided on this website is not a substitute for professional medical care. If you have any concerns about your health or medicine, you should consult your healthcare specialist or general practitioner. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
Reporting Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine.
